Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin and Hydroxychloroquine in Hepatitis C
NCT01833845Phase 2Terminated
- Sponsor
- BioLineRx Ltd.
- Start
- Apr 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in hepatitis C (HCV), sponsored by BioLineRx Ltd.. Started Apr 2013; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01833845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01833845.